-
Cardiac medical device startup Mardil seeks $12 million to treat mitral valves
Mardil, one of the newest companies based in Minnesota, wants to create a new innovative medical device that treats sloppy mitral valves short of doing open-heart surgery. It is trying to raise up to $12 million.
-
Dell buy puts medical images in the cloud (Morning Read)
Dell said it will acquire Insite One, a developer of applications that enables doctors to share medical images in the cloud, for an undisclosed price, reports VentureBeat.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Detroit Venture Partners [hearts] Motor City (Morning Read)
Detroit Venture Partners wants its portfolio companies to move their operations to the heart of Detroit in the hopes of transforming the Motor City into a vibrant startup community like Boston and San Francisco, according to Xconomy Detroit.
-
Dealmaking machine Sanofi to buy Avila for $800M (Morning Read)
The dealmaking machine that is Sanofi-Aventis is at it again, signing an oncology drug pact with Avila Therapeutics in Waltham, Massachusetts, worth $40 million up front and up to $154 million in milestone payments per program. Overall, the deal is valued at $800 million, according to FierceBiotech.
-
Stanford docs may be too cozy with drug companies (Morning Read)
As medical schools wrestle with how to keep drug companies from corrupting their faculties, Stanford University often is lauded for its tough stance. But a ProPublica investigation found that more than a dozen of the school’s doctors were
-
Devices & Diagnostics, Hospitals, Policy
Medtronic gives artificial pancreas a brain (Weekend Rounds)
The artificial pancreas just got a brain. Medtronic Inc. (NYSE:MDT) said Monday the Food and Drug Administration has approved software that helps manage a patient’s diabetes therapy.
-
Women anguish over FDA’s Avastin pull (Morning Read)
The Food and Drug Administration on Thursday moved toward revoking approval of the blockbuster cancer drug Avastin as a treatment for breast cancer, drawing criticism for limiting treatment options for desperately ill women, reports the Chicago Tribune.
-
Health reform politics play out over generation (Morning Read)
As the history of social legislation suggests — and as this week’s federal court ruling on the so-called individual mandate makes clear, the effects of healthcare reform on our politics may not be settled until a lot of President Obama’s aides are collecting Medicare checks, according to the New York Times.
-
ObamaCare: Facing down Grinch or Sanity Clause?(Morning Read)
The U.S. Constitution’s Commerce Clause states that Congress has the power to “regulate Commerce … among the several States.” To supporters of health reform, the Commerce Clause is the Grinch that stole Obamacare, writes the Health Care Blog. To opponents, it might seem like a Sanity Clause.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Theken Spine wins $200K Ohio grant to unify spinal fusion firms
The Ohio Controlling Board today approved Theken Spine LLC for a $200,000 Rapid Outreach grant to buy new machinery and equipment. The Akron maker of implantable hardware for spinal fusion surgery is consolidating four facilities at a Medina building, which will be renovated and used for offices, warehousing and product manufacturing.
-
PleuraFlow active chest tube-clearing device wins FDA approval
Cleveland Clinic spinoff Clear Catheter Systems, which recently closed a $1.2 million angel investment round, has received FDA approval to sell its PleuraFlow Active Tube-Clearance System in the United States. PleuraFlow keeps catheters clear while draining blood and other fluids from the chest after heart or lung surgery.
-
On the road to healthcare rationing (Morning Read)
Unequal access to healthcare is hardly a new phenomenon in the United States, but the country is moving toward rationing at an unprecedented pace. The underlying problem is that doctors are reimbursed at different rates, reports the New York Times.
-
Congressional leaders fear 510(k) changes (Weekend Rounds)
A bipartisan group of 15 senators sent a letter to FDA Commissioner Dr. Margaret Hamburg urging her agency, among other things, to adopt a more deliberate, cautious approach to amending 510(k). And Orthopedics company Stryker Corp. has agreed to sell a product line including the bone growth putty that has caused the company so much legal grief to Olympus Corp. for $60 million.
-
Cleveland medical mart project to break ground in January
The long-awaited groundbreaking for Cleveland’s $465 million medical mart project will be… drum roll, please… Jan. 14, 2011. The ceremonial turning of the ground “on the historic Cleveland Malls” will happen at 11 a.m. that Friday, according to MMPI, the Chicago-based property developer that’s leading the project. The event, which also will feature remarks from civic, business and government leaders, is free and open to the public.
-
Obama hails bill averting doc pay cut… for now (Morning Read)
The U.S. House gave final approval on Thursday to a bill that would avert a 25 percent cut in Medicare payments to doctors by freezing reimbursement rates at current levels until the end of next year, reports the New York Times. President Obama, who hailed the nearly unanimous action by Congress, promised to sign the legislation.